Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
24.92
+0.16 (0.65%)
At close: Nov 18, 2025, 4:00 PM EST
24.87
-0.05 (-0.20%)
After-hours: Nov 18, 2025, 7:59 PM EST
Moderna Market Cap
Moderna has a market cap or net worth of $9.74 billion as of November 18, 2025. Its market cap has decreased by -53.40% in one year.
Market Cap
9.74B
Enterprise Value
3.76B
1-Year Change
-53.40%
Ranking
Category
Stock Price
$24.92
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $9.74B, an increase of 59.14%. That is a compound annual growth rate of 6.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 9.67B | -39.54% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | 41.34B | 534.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |